Trial Profile
Effect of Golimumab treatment on work productivity and activity and quality of life in patients with Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2018
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Psoriatic arthritis; Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms Go Active
- 24 Oct 2018 Interim results presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
- 16 Jul 2018 New trial record
- 16 Jun 2018 Interim results (n=167) presented at the 19th Annual Congress of the European League Against Rheumatism.